Results 241 to 250 of about 2,907,437 (262)
Some of the next articles are maybe not open access.
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
The Lancet Oncology, 2015 J. Bruix, T. Takayama, V. Mazzaferro, G. Chau, Jiamei Yang, M. Kudo, J. Cai, R. Poon, K. Han, W. Tak, H. Lee, T. Song, S. Roayaie, L. Bolondi, K. Lee, M. Makuuchi, F. Souza, M. Berre, G. Meinhardt, J. Llovet +19 moresemanticscholar +1 more sourceRandomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
The Lancet, 1998 W. Hacke, M. Kaste, C. Fieschi, R. Kummer, A. Dávalos, Dieter Meier, V. Larrue, E. Bluhmki, S. Davis, G. Donnan, D. Schneider, E. Díez-Tejedor, P. Trouillas +12 moresemanticscholar +1 more sourceBevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
The Lancet, 2007 B. Escudier, A. Płużańska, P. Koralewski, A. Ravaud, S. Bracarda, C. Szczylik, C. Chevreau, Marek Filipek, B. Melichar, E. Bajetta, V. Gorbunova, J. Bay, I. Bodrogi, A. Jagiełło-Gruszfeld, N. Moore +14 moresemanticscholar +1 more source